Back
Vistagen Therapeutics Quote, Financials, Valuation and Earnings
Sell
41
VTGN
Vistagen Therapeutics
Last Price:
4.45
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
Vistagen Therapeutics Price Quote
$4.45
+0.01 (+0.23%)
(Updated: May 20, 2024 at 11:36 AM ET)
Vistagen Therapeutics Key Stats
Sell
41
Vistagen Therapeutics (VTGN)
is a Sell
Day range:
$4.44 - $4.57
52-week range:
$1.62 - $24.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
57.48
P/B ratio:
0.97%
Volume:
76.9K
Avg. volume:
174.1K
1-year change:
2.07%
Market cap:
$120M
Revenue:
-$227.3K
EPS:
$-3.51
How Much Does Vistagen Therapeutics Make?
-
How Much Are Vistagen Therapeutics's Sales Annually?
VTGN Revenues are -$227.3K -
How Much Profit Does Vistagen Therapeutics's Make A Year?
VTGN net income is -$59.2M
Is Vistagen Therapeutics Growing As A Company?
-
What Is Vistagen Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.29% -
What Is Vistagen Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Vistagen Therapeutics Stock Price Performance
-
Did Vistagen Therapeutics Stock Go Up Last Month?
Vistagen Therapeutics share price went down by -4.93% last month -
Did VTGN's Share Price Rise Over The Last Year?
VTGN share price rose by 2.07% over the past 1 year
What Is Vistagen Therapeutics 52-Week High & Low?
-
What Is Vistagen Therapeutics’s 52-Week High Share Price?
Vistagen Therapeutics has traded as high as $24.71 over the past 52 weeks -
What Is Vistagen Therapeutics’s 52-Week Low Share Price?
Vistagen Therapeutics has traded as low as $1.62 over the past 52 weeks
Vistagen Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Vistagen Therapeutics?
-
How Much Debt Does Vistagen Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Vistagen Therapeutics Have?
Cash and short term investments quarterly total is $126.6M -
What Is Vistagen Therapeutics’s Book Value Per Share?
Book value per share is 4.56
Is Vistagen Therapeutics Cash Flow Positive?
-
What Is VTGN Cash Flow From Operations?
Cash flow from operations (TTM) is -$26.1M -
What Is Vistagen Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $128.2M -
What Is Vistagen Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$560.6K
Vistagen Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
VTGN return on invested capital is -80.23% -
What Is Vistagen Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -67.06% -
What Is VTGN Return On Equity?
ROE is a measure of profitability and is -80.76%
Vistagen Therapeutics Earnings Date & Stock Price
-
What Is Vistagen Therapeutics's Stock Price Today?
A single share of VTGN can be purchased today for 4.44 -
What Is Vistagen Therapeutics’s Stock Symbol?
Vistagen Therapeutics trades on the nasdaq under the ticker symbol: VTGN -
When Is Vistagen Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Vistagen Therapeutics is scheduled on June 28, 2024 -
When Is VTGN's next ex-dividend date?
Vistagen Therapeutics's next ex-dividend date is May 20, 2024 -
How To Buy Vistagen Therapeutics Stock?
You can buy Vistagen Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Vistagen Therapeutics Competitors
-
Who Are Vistagen Therapeutics's Competitors?
Below is a list of companies who compete with Vistagen Therapeutics or are related in some way:
Vistagen Therapeutics Dividend Yield
Data Unavailable
Vistagen Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 19.51% |
| Revenue: | 129.07% | -24.44% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 13.25 |
| Upside from Last Price: | 198.42% |